In Vitro and In Vivo Analysis of the Mg-Ca-Zn Biodegradable Alloys
- PMID: 38921539
- PMCID: PMC11204402
- DOI: 10.3390/jfb15060166
In Vitro and In Vivo Analysis of the Mg-Ca-Zn Biodegradable Alloys
Abstract
The objective of this work was to analyze the in vitro and in vivo tests of a novel Mg-based biodegradable alloy-Mg-0.5%Ca-with various amounts of Zn (0.5, 1, 1.5, 2.0, and 3.0 wt.%). In terms of in vitro biocompatibility, MTT and Calcein-AM cell viability assays, performed on the MG-63 cell line through the extract method, revealed that all five alloy extracts are non-cytotoxic at an extraction ratio of 0.025 g alloy per mL of cell culture medium. In the in vivo histological analysis, Mg-0.5Ca-1.5Zn demonstrated exceptional potential for stimulating bone remodeling and showed excellent biocompatibility. It was observed that Mg-0.5Ca-0.5Zn, Mg-0.5Ca-1.5Zn, and Mg-0.5Ca-3Zn displayed good biocompatibility. Furthermore, the histological examination highlighted the differentiation of periosteal cells into chondrocytes and subsequent bone tissue replacement through endochondral ossification. This process highlighted the importance of the initial implant's integrity and the role of the periosteum. In summary, Mg-0.5Ca-1.5Zn stands out as a promising candidate for bone regeneration and osseointegration, supported by both in vitro and in vivo findings.
Keywords: Mg-Ca-Zn alloys; biocompatibility; in vitro analysis; in vivo tests.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures






Similar articles
-
In vivo performance of a rare earth free Mg-Zn-Ca alloy manufactured using twin roll casting for potential applications in the cranial and maxillofacial fixation devices.Bioact Mater. 2021 Oct 23;12:85-96. doi: 10.1016/j.bioactmat.2021.10.026. eCollection 2022 Jun. Bioact Mater. 2021. PMID: 35087965 Free PMC article.
-
In vitro and in vivo assessment of squeeze-cast Mg-Zn-Ca-Mn alloys for biomedical applications.Acta Biomater. 2022 Sep 15;150:442-455. doi: 10.1016/j.actbio.2022.07.040. Epub 2022 Jul 29. Acta Biomater. 2022. PMID: 35914693
-
In vitro and in vivo assessment of biomedical Mg-Ca alloys for bone implant applications.J Appl Biomater Funct Mater. 2018 Jul;16(3):126-136. doi: 10.1177/2280800017750359. Epub 2018 Apr 2. J Appl Biomater Funct Mater. 2018. PMID: 29607729
-
Microstructural, mechanical and corrosion characteristics of heat-treated Mg-1.2Zn-0.5Ca (wt%) alloy for use as resorbable bone fixation material.J Mech Behav Biomed Mater. 2017 May;69:203-212. doi: 10.1016/j.jmbbm.2017.01.005. Epub 2017 Jan 5. J Mech Behav Biomed Mater. 2017. PMID: 28088072
-
Electrochemical Analysis and In Vitro Assay of Mg-0.5Ca-xY Biodegradable Alloys.Materials (Basel). 2020 Jul 10;13(14):3082. doi: 10.3390/ma13143082. Materials (Basel). 2020. PMID: 32664267 Free PMC article.
References
-
- Sommer N.G., Hirzberger D., Paar L., Berger L., Ćwieka H., Schwarze U.Y., Herber V., Okutan B., Bodey A.J., Willumeit-Römer R., et al. Implant degradation of low-alloyed Mg–Zn–Ca in osteoporotic, old and juvenile rats. Acta Biomater. 2022;147:427–438. doi: 10.1016/j.actbio.2022.05.041. - DOI - PubMed
-
- Rout P.K., Roy S., Rathore D. Recent advances in the development of Mg-Ca-Zn alloys as biodegradable orthopedic implants. Mater. Today Proc. 2023. in press, corrected proof . - DOI
-
- Sahu M.R., Kumar T.S.S., Chakkingal U. A review on recent advancements in biodegradable Mg-Ca alloys. J. Magnes. Alloys. 2022;10:2094–2117. doi: 10.1016/j.jma.2022.08.002. - DOI
Grants and funding
LinkOut - more resources
Full Text Sources